Evidence map›Paper›PMID 21281871›Full record

Trial reportThe Journal of allergy and clinical immunology2011

The Madison Avenue effect: how drug presentation style influences adherence and outcome in patients with asthma.

Emmanuelle M Clerisme-Beaty, Susan J Bartlett, W Gerald Teague, John Lima, Charles G Irvin, Rubin Cohen, Mario Castro, Robert A Wise, Cynthia S Rand

Open access · greenAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in The Journal of allergy and clinical immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 3 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 3 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. White patients' physical responses to healthcare treatments are influenced by provider race and gender.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Trial
  5. Trial
  6. What Really Happens in the Home: The Medication Environment of Urban, Minority Youth.The journal of allergy and clinical immunology. In practice
    Trial
  7. An Overview of Adherence-What It Is and Why It Is Important.The journal of allergy and clinical immunology. In practice · 2024
    Review
  8. Article
  9. Article
  10. Review
  11. Longitudinal associations between asthma control, medication adherence, and quality of life among adolescents: results from a cross-lagged analysis.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2015
    Article
  12. Article
  13. Article
  14. Medication adherence in the asthmatic child and adolescent.Current allergy and asthma reports · 2011
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 2 countries.

Emmanuelle M Clerisme-BeatyJohns Hopkins University, Baltimore, MD, USA. crand@jhmi.edu
Susan J Bartlett
W Gerald Teague
John Lima
Charles G Irvin
Rubin Cohen
Mario Castro
Robert A Wise
Cynthia S Rand
Johns Hopkins University · USAlbert Einstein College of Medicine · USJohns Hopkins Medicine · USMcGill University · CANemours Children’s Clinic · USUniversity of Vermont · USUniversity of Virginia · USWashington University in St. Louis · US

Funding

MULTIDISCIPLINARY TRAINING PROGRAM IN LUNG DISEASEST32HL007534 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Nadia N Hansel, Larissa A. Shimoda · 1985 to 2026
$28.3M
The Placebo Effect in AsthmaR01HL073494 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI WISE, ROBERT A. · 2002 to 2005
$2.4M
NHLBI NIH HHS R01 HL073494NHLBI NIH HHS R01HL073494NHLBI NIH HHS T32 HL007534
6 · The paper itself

Abstract

backgroundLittle is known about how drug presentation influences medication adherence.

objectiveTo examine the effect of an educational program aimed at increasing expectations of treatment benefit on medication adherence.

methodsData are analyzed from 99 participants who underwent electronic drug monitoring during the Trial of Asthma Patient Education, a randomized, placebo-controlled, multicenter trial. Participants with suboptimally controlled asthma were randomized to placebo or montelukast in conjunction with a presentation mode that was either neutral or designed to increase outcome expectancy. Adherence was monitored electronically over 4 weeks and was defined as ≥ 80% use of prescribed doses. Outcome expectancy, peak expiratory flow, prebronchodilator FEV₁, asthma control (Juniper asthma control questionnaire), and asthma-related quality of life were assessed at baseline and at the 4-week follow-up.

resultsAverage electronic medication adherence was 69.9%. There was a significant interaction between presentation mode and drug assignment, with participants in the enhanced/montelukast group having a higher change in outcome expectancy (Δ 2.1 points; P < .001) and better medication adherence (odds ratio, 4.0; 95% CI, 1.1-14.3) compared with those in the neutral/placebo group. There was no difference in asthma symptoms, quality of life, or clinical outcomes on the basis of presentation mode. Rather, increased outcome expectancy was associated with modest improvements in asthma symptoms after adjusting for presentation mode, drug assignment, and medication adherence.

conclusionThe use of an enhanced presentation aimed at increasing outcome expectancy may lead to improved medication adherence.

Indexed as

Medication AdherenceAdultAsthmaFemaleForced Expiratory VolumeHumansLungMaleMiddle AgedPatient Education as TopicTreatment Outcome

Identifiers

PMID21281871
PMCPMC3050545
OpenAlexW2047986475

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.